Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2008
12/09/2008CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
12/09/2008CA2250188C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
12/04/2008WO2008147167A1 Pharmaceutical composition comprising the combinaton of the anti-microbial agent ciprofloxacin and the antioxidant agent ascorbic acid for the treatment of urinary infections
12/04/2008WO2008146914A1 Heterocyclic compound
12/04/2008WO2008145064A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300230 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
12/04/2008US20080300219 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
12/04/2008US20080299219 Having at least 3% deuterium; anticholinergic agent for treating overactive bladder.
12/04/2008US20080299218 Deuterium-enriched valsartan
12/04/2008US20080299217 Deuterium-enriched bifeprunox
12/04/2008US20080299215 Deuterium-enriched lestaurtinib
12/04/2008US20080299213 Augmentation and repair of spincter defects with cells including adipocytic cells
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/03/2008EP1997829A1 Albumin fusion proteins
12/03/2008EP1541554B1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1430031B1 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008CN101316934A Pde inhibitors and combinations thereof for the treatment of urological disorders
12/03/2008CN101316842A Acid addition salt of optically active dihydropyridine derivative
12/03/2008CN101316839A Acid addition salt of dihydropyridine derivative
12/03/2008CN101314004A Medicament for treating gynaecologic urinary system infection contamination and preparation method thereof
12/03/2008CN101313972A Technique for preparing new preparation of six ingredients with rehmannia
12/03/2008CN101313971A Chinese medicine composition for treating nephropathy
12/03/2008CN101313961A Medicinal composition for treating uracratia
12/03/2008CN101313956A Compound chrysanthemum capsule
12/03/2008CN101313943A Chinese medicinal composition for treating nephropathy and preparation thereof
12/03/2008CN101313942A Chinese medicine composition for treating nephropathy
12/03/2008CN101313926A Transcription regulating and controlling article composition
12/03/2008CN101313922A Method for obtaining extract from several frequently seen plants and uses of the extract
12/03/2008CN101313920A Application of truffle extract in preparing foods, medicine for treating endocrine dyscrasia diseases
12/03/2008CN101313914A Uses and preparations of common camptotheca fruit glycosides of common camptotheca fruit extract
12/03/2008CN101313749A Male silk moth capsule and its preparing process
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
12/03/2008CN100439397C Crystallization of IGF-1
12/03/2008CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100438905C Stable liquid formulations of botulinum toxin
12/03/2008CN100438866C Use of rare earth compounds for the prevention of kidney stone disease
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459430 Calcium channel modulator; delayed or sustained release
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them
11/2008
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008143239A1 Crystalline micropowder particles
11/27/2008WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
11/27/2008WO2008142140A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/27/2008WO2008141462A1 Novel case of renin inhibitors
11/27/2008WO2008141353A1 Prevention of acute kidney injury
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors
11/27/2008US20080293791 Valsartan salts
11/27/2008US20080293779 Methods of treating humans undergoing injection of a contrast agent
11/27/2008US20080293774 Treatment of the Symptoms of Bladder Irritation
11/27/2008US20080293764 Lpa receptor antagonist
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293621 Methods for Prolonging Feline Life
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687955A1 Crystalline micropowder particles
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687426A1 Prevention of acute kidney injury
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008CN101312748A 抗体-药物轭合物和使用方法 Antibodies - drug conjugates and methods of use
11/26/2008CN101310764A Traditional Chinese medicine preparation for treating renal atrophy
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436414C Azabicyclo derivatives as muscarinic receptor antagonists
11/26/2008CN100435840C Medicament for treating hyperplasia of prostate
11/26/2008CN100435793C Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
11/26/2008CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008CA2449922C Pharmaceutical composition for therapy of interstitial cystitis
11/25/2008CA2276606C Method of treating prostatic diseases using active vitamin d analogues
11/20/2008WO2008140812A2 Compositions and methods comprising klk3, psca, or folh1 antigen
11/20/2008WO2008140125A1 Pharmaceutical composition for prevention of peritoneal fibrosis
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139574A1 Crystalline form of lactam compound and process for producing the same
11/20/2008WO2008138483A1 sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 562